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THE PUBLIC SECTOR S ROLE IN 
BIOTECHNOLOGY RESEARCH
The concept that the public sector has a major role to play in research — 
and particularly in agricultural research — is an historic one. It was part 
of the original mandate for the Department of Agriculture (USDA) in 
1862, but perhaps its strongest expression came in 1887 with the passage of 
the Hatch Act to establish the land-grant sys-
tem of universities. Recognizing that it is in the 
public interest to supply funds to finance re-
search, the land-grant philosophy of research, 
education, and public service has been the 
foundation of America’s agricultural produc-
tivity for nearly 125 years.
Thus the acknowledgment by government — 
and the public — that agricultural research is a 
valuable use of tax dollars has an historic basis 
— and a foundation that has continued to be 
solid over the years as the investment is paid 
back many times in vital contributions to agri-
culture, to the consumer, and to the national 
economy.
Overall, in the United States, the government has tended to take on the 
role of funding more fundamental research. Thus, not every project will 
have a clear end product, but maybe geared toward increasing our knowl-
edge about the functioning of organisms at the cellular and molecular 
level. As a result, the public sector has played, and will continue to play, a 
major role in doing fundamental research which contributes to the foun-
dation of the biotechnology industry.
High-risk research is also an area which is ripe for public funding. As 
part of their development, biotechnology firms are going through an evo-
lution. Following an initial large investment of venture capital, there were 
hopes for the quick generation of substantial returns. But as the first flush 
of excitement and expectation has died down, reality has set in in terms of 
the time needed to get products out into the marketplace.
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As companies become more market-oriented, universities and govern-
ment are playing an increasingly central role in doing high-risk work. For 
example, not too many biotechnology firms are doing salt tolerance or 
drought tolerance research because there are uncertainties about whether 
it will work. Therefore, research on this important trait has fallen to the 
public sector.
In addition, I do not want to overlook the equally significant responsi-
bility of the universities in training the young men and women who will 
become employees in the biotechnology industry and faculty in the uni-
versities. To meet the growing demand for qualified people to guide future 
technologies, we must attract top-notch young men and women to science 
and agriculture, train them well, and endeavor to increase the racial, cul-
tural, and gender diversity of that brain pool. Young people are the life-
blood of any long-term research endeavor.
TECHNOLOGY TRANSFER
There is growing concern that although the U.S. is preeminent in basic re-
search we fall behind other countries in turning that knowledge into 
products. While the movement of graduate and postdoctoral students 
from the university to industry has always been one way in which technol-
ogy transfer is accomplished, the passage of the Federal Technology Trans-
fer Act in 1986 was a major advance. It clearly established the appropriate-
ness of government scientists working closely with industry to facilitate 
application of their research results.
Not only is the Agricultural Research Service (ARS) aggressively imple-
menting the Act’s provisions, but USDA has been directed by Congress to 
increase developmental research within ARS. In addition, I chair a task 
force which is developing specific mechanisms for promoting closer coop-
erative interaction among federal, state, university, and industrial scien-
tists. Our goal is to facilitate the utilization of discoveries and inventions 
originating in USDA and State Agricultural Experiment Station Laborato-
ries for the benefit of society.
REGULATORY UNCERTAINTY
The public sector has a role in two major issues that will determine the fu-
ture of biotechnology: 1) regulatory uncertainty and 2) public perception.
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In terms of the 
public percep-
tion, it is part 
of our role as 
scientists and 
end users of 
technology to 
get across to 
the public the 
facts it needs 
to make in-
formed deci-
sions — to 
help people 
look at the big 
picture and 
weigh the 
long-term 
benefits and 
costs.
We have been working for the past year on developing a definition of 
the scope of organisms which should receive regulatory oversight. The 
publication of guidelines for field testing of “organisms with deliberately 
modified hereditary traits” — genetically modified organisms — was an 
example of how this definition could be used.
The regulatory framework for biotechnology should be based on sound 
scientific principles, in which oversight is commensurate with the level of 
risk. We have three major goals: 1) to avoid singling out recombinant- 
DNA technology as being any more risky than other procedures used to 
modify an organism; 2) to refrain from unduly hindering research with 
burdensome and unnecessary overregulation; and 3) to provide assurance 
to the public that there is adequate review prior to the release of modified 
organisms if we are unfamiliar with how they will affect the environment 
or health.
PUBLIC PERCEPTION
Some people feel that we should not use the term “genetically modified or-
ganisms” because it indicates there is risk. The issue is that there is already 
a public perception of risk — and to much of the public, perception is re-
ality. This issue must be resolved or else the great potential of biotechnol-
ogy will not be realized.
In terms of the public perception, it is part of our role as scientists and 
end users of technology to get across to the public the facts it needs to 
make informed decisions — to help people look at the big picture and 
weigh the long-term benefits and costs. I take exception to those who 
would paint biotechnology as competing with sustainable agriculture for 
funding. Sustainable agriculture is a systems approach to producing food 
and fiber efficiently, economically, and in harmony with the environment. 
As a systems approach, it needs input from ecologists, soil scientists, com-
puter scientists, systems engineers, and economists.
It also needs molecular biologists and biotechnologists who now have 
the tools to ask questions about the molecular and biochemical basis of 
desirable traits such as disease and insect resistance and photosynthetic 
efficiency (we currently use less than one percent of the sun’s radiation).
In addition, we can delete components in food that are detrimental to 
health and add others that are beneficial. Thus, biotechnology can help 
agriculture be sustainable, productive and nutritious.
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Another mechanism for addressing public concerns is risk assessment re-
search. For the first time, the Farm Bill explicitly directs USDA to support 
biotechnology risk assessment research. The bill directs the Secretary of 
Agriculture to establish a grant program to fund research on methods to 
confine introduced organisms, monitor their dispersal, study potential 
gene transfer, and investigate other areas in which biosafety information 
may be incomplete.
To support this research, USDA will designate one percent of its 
biotechnology research funding exclusively for risk assessment work. Al-
though the Department is still looking at budget data and discussing the 
details of implementing this legislation, it is likely that the funding level 
for risk assessment research will be about $1 million a year.
FUNDING
In closing, I would like to address the issue of funding for biotechnology 
research. In 1987, the National Research Council (NRC) published a re-
port on Agricultural Biotechnology — Strategies for National Competitive-
ness which recommended that in order for agricultural biotechnology to 
reach its full potential, a $500 million investment should be made in fun-
damental research in the agricultural biological sciences.
Congressman George Brown picked up on this recommendation and 
suggested a national institute of agriculture funded at the $500 million 
level. Then, in 1989, the Board on Agriculture of the National Research 
Council published a report entitled Investing in Research —A Proposal to 
Strengthen the Agricultural Food and Environmental System.
These two NRC reports formed the basis for the National Research Ini-
tiative on Agriculture, Food, and the Environment. This initiative was 
launched in the President’s FY1991 budget with a recommendation for 
funding in its first year at $100 million and a commitment to add $50 mil-
lion in each of the outyears — provided that funds were appropriated on a 
non-earmarked basis. In the same year, Congress authorized funding of 
the initiative at the recommended level of $500 million per year, reaching 
that amount of funding by 1995.
As you know, the authorization and appropriations process are two dis-
tinct activities. In FY 1991, Congress appropriated $73 million, and in the
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FY1992 budget currently being considered by the appropriations commit-
tees, the President has recommended funding at $125 million. In addition, 
there is a $25 million competitive facilities program which is an attempt to 
address the earmarking problem.
Although not all of these funds are dedicated to biotechnology, a con-
siderable amount in the plant and animal systems areas will support basic 
work needed to effectively use the tools of biotechnology. In the $35 mil-
lion for plant systems, $11 million is dedicated to map genes that regulate 
agriculturally important traits such as insect and disease resistance and 
drought tolerance. In the $53 million recommended in FY 1992, $18 mil-
lion is recommended for genetic mapping.
FCCSET
There is also a new federal approach to research funding through the 
Office of Science and Technology Policy (OSTP) which operates the Fed-
eral Coordinating Committee of Science and Engineering Technology 
(FCCSET). The purpose of FCCSET is to bring together agencies across 
the government which have interest and expertise in a particular priority 
area — for example, global climate change. By “comparing notes,” so to 
speak, we establish a baseline picture of what is going on. We can see the 
overlaps — and the gaps.
Just as a doctor would use an X-ray to guide her in choosing a treat-
ment, the baseline picture helps us develop a research plan. Each agency 
then develops that part of the plan in which it can make the best contribu-
tion. Furthermore, by bringing the Office of Management and Budget 
(OMB) into the planning stage, we can assure that each group’s part of the 
overall plan does become part of that agency’s budget. FCCSET is a suc-
cessful strategy to coordinate research planning and budgeting and to es-
tablish national research priorities.
Last year, in addition to global climate change, FCCSET added two 
more areas to the planning process: high-performance computing, and 
science and mathematics education. While across government there is an 
overall attempt to keep the budget less than inflation, all three initiatives 
received increased funding in the President’s FY 1992 budget. When 
FCCSET met a few weeks ago, two other candidates were proposed for the 
planning process: advanced materials and processes, and biotechnology.
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We will start out doing a “crosscut” to determine the current level of 
funding and then plan for the outyears of 1993 to 1995. It is too early to 
know whether this exercise will turn into an initiative as did global climate 
change, high-performance computing, and science and mathematics edu-
cation, but this is the first step — which may then lead to a component in 
the President’s 1993 budget.
CONCLUSION
From ancient civilizations to our current technologically advanced soci-
ety, national leaders have understood that new scientific knowledge can be 
a tremendous instrument of national strength and public good.
A strong national commitment to public funding of agricultural re-
search, technology, and education is essential to the short- and long-term 
interests of both the U.S. and the world. Secretary of Agriculture Ed 
Madigan has stated (House testimony 4/17/91) that “like other sectors of 
the economy, agriculture is increasingly dependent upon technological 
advances to ... meet immediate and long-term challenges....”
The role of the public sector in helping agricultural research meet those 
challenges has historically been a central one — and it will surely remain 
so. I foresee the strong continuation of investment in publicly-funded 
agricultural biotechnology research in the United States, which I feel is 
essential to achieve the goals of an economically and environmentally 
sustainable agriculture.
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